VACC Insider Trading Activity and SEC Form 4 Filings
VACC insider trading summary
No open-market insider purchases or sales of Vaccitech plc (VACC) have been reported on SEC Form 4 in the past 12 months.
Latest VACC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 26, 2023 | Joseph Scheeren | Director | Buy | $24K (10,000 @ $2.44) |
| May 25, 2023 | Robin Wright | Director | Buy | $37K (13,750 @ $2.66) |
| Mar 27, 2023 | William Enright | Chief Executive Officer | Sell | $36K (15,000 @ $2.42) |
| Aug 25, 2022 | Graham Griffiths | Chief Business Officer | Sell | $74K (10,000 @ $7.39) |
| Aug 25, 2022 | Christopher Ellis | Chief Operating Officer | Sell | $177K (25,000 @ $7.07) |
| Aug 25, 2022 | Christopher Ellis | Chief Operating Officer | Sell | $81K (14,176 @ $5.69) |
| Aug 24, 2022 | Christopher Ellis | Chief Operating Officer | Sell | $2K (450 @ $4.78) |
| Aug 18, 2022 | Christopher Ellis | Chief Operating Officer | Sell | $11K (2,175 @ $4.84) |
| Aug 17, 2022 | Christopher Ellis | Chief Operating Officer | Sell | $3K (649 @ $4.77) |
| Aug 17, 2022 | Graham Griffiths | Chief Business Officer | Sell | $2K (500 @ $4.76) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.